HealthDay News -- Patients who receive an implantable cardioverter-defibrillator (ICD) at a high-volume hospital rather than a low-volume hospital are less likely to have an adverse event related to the procedure, according to research published in the Sept. 28 issue of the Journal of the American College of Cardiology.
